Cargando…

Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis

Introduction: Linezolid (LNZ) is an effective antibiotic to treat patients with multidrug-resistant tuberculosis (MDR-TB) treatment failure. M. tuberculosis strains resistant to isoniazid and rifampin are defined as MDR-TB. In recent years, resistance to LNZ among MDR-TB cases has been reported in s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azimi, Taher, Khoshnood, Saeed, Asadi, Arezoo, Heidary, Mohsen, Mahmoudi, Hassan, Kaviar, Vahab Hassan, Hallajzadeh, Masoume, Nasiri, Mohammad Javad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468755/ https://www.ncbi.nlm.nih.gov/pubmed/36110536 http://dx.doi.org/10.3389/fphar.2022.955050

Ejemplares similares

Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis
por: Khoshnood, Saeed, et al.
Publicado: (2021)

The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis
por: Sholeh, Mohammad, et al.
Publicado: (2023)

A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19
por: Heidary, Mohsen, et al.
Publicado: (2022)

Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis
por: Yuan, Yuan, et al.
Publicado: (2022)

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis
por: Zhang, Haoyue, et al.
Publicado: (2023)

Molecular typing and antibiotic resistance patterns among clinical isolates of Acinetobacter baumannii recovered from burn patients in Tehran, Iran
por: Maleki, Abbas, et al.
Publicado: (2022)

The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis
por: Shirani, Maryam, et al.
Publicado: (2023)

Trends in multidrug-resistant tuberculosis in Tehran, Iran: an analysis of published data
por: Nasiri, Mohammad Javad, et al.
Publicado: (2019)

Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India
por: Resendiz-Galvan, Juan Eduardo, et al.
Publicado: (2023)

Comparison of Rifabutin-Based Versus Rifampin-Based Regimens for the Treatment of Mycobacterium avium Complex: A meta-Analysis Study
por: Hajikhani, Bahareh, et al.
Publicado: (2021)

Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination
por: Du, Jian, et al.
Publicado: (2021)

Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus
por: Negatu, Dereje A., et al.
Publicado: (2023)

Amoxicillin-docosahexaenoic acid encapsulated chitosan-alginate nanoparticles as a delivery system with enhanced biocidal activities against Helicobacter pylori and improved ulcer healing
por: Khoshnood, Saeed, et al.
Publicado: (2023)

Cytotoxicity of the Sesquiterpene Lactones Neoambrosin and Damsin from Ambrosia maritima Against Multidrug-Resistant Cancer Cells
por: Saeed, Mohamed, et al.
Publicado: (2015)

Intrathecal/Intraventricular Linezolid in Multidrug-Resistant Enterococcus faecalis Ventriculitis
por: Lich, Brian F., et al.
Publicado: (2016)

Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis
por: Mase, Anjeli, et al.
Publicado: (2022)

Obesity and gut–microbiota–brain axis: A narrative review
por: Asadi, Arezoo, et al.
Publicado: (2022)

In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis
por: Hoffmann, Ada Marie, et al.
Publicado: (2022)

The Status of Carbapenem Resistance in Cystic Fibrosis: A Systematic Review and Meta-Analysis
por: Saadh, Mohamed J., et al.
Publicado: (2022)

Prevalence of Drug-resistant Klebsiella pneumoniae in Iran: A Review Article
por: HEIDARY, Mohsen, et al.
Publicado: (2018)

Molecular Analysis of Linezolid-Resistant Clinical Isolates of Mycobacterium abscessus
por: Ye, Meiping, et al.
Publicado: (2019)

Linezolid-resistant Mycobacterium tuberculosis: Will it impact the tuberculosis elimination programme?
por: Bharadwaj, Renu
Publicado: (2021)

Prevalence of antibiotic resistance in Escherichia coli strains simultaneously isolated from humans, animals, food, and the environment: a systematic review and meta-analysis
por: Pormohammad, Ali, et al.
Publicado: (2019)

Linezolid Toxicity and Mitochondrial Susceptibility: A Novel Neurological Complication in a Lebanese Patient
por: Abou Hassan, Ossama K., et al.
Publicado: (2016)

The Inhibition Effect of Linezolid With Reyanning Mixture on MRSA and its Biofilm is More Significant than That of Linezolid Alone
por: Zhang, Lulu, et al.
Publicado: (2022)

Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment
por: Heidary, Mohsen, et al.
Publicado: (2022)

Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?
por: Grard, Soazic, et al.
Publicado: (2015)

Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France
por: Jaspard, Marie, et al.
Publicado: (2020)

Linezolid Resistance in Staphylococci
por: Stefani, Stefania, et al.
Publicado: (2010)

A Case Report and Literature Review of the Outcome of Linezolid-Induced Optic and Peripheral Neuropathy in Patients With Multidrug-Resistant Pulmonary TB
por: Bano, Safia, et al.
Publicado: (2022)

Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance
por: Gawryszewska, I., et al.
Publicado: (2017)

Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites
por: El-Readi, Mahmoud Zaki, et al.
Publicado: (2021)

Linezolid- and Multidrug-Resistant Enterococci in Raw Commercial Dog Food, Europe, 2019–2020
por: Freitas, Ana R., et al.
Publicado: (2021)

Nanodrug delivery in reversing multidrug resistance in cancer cells
por: Kapse-Mistry, Sonali, et al.
Publicado: (2014)

Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
por: Lee, Nan-Yao, et al.
Publicado: (2019)

Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs)
por: Gil, José Pedro, et al.
Publicado: (2021)

Research Progress on Natural Diterpenoids in Reversing Multidrug Resistance
por: Deng, Zhuo-fen, et al.
Publicado: (2022)

Editorial: Novel Approaches to the Treatment of Multidrug-Resistant Bacteria
por: Pusparajah, Priyia, et al.
Publicado: (2022)

Bedaquiline, pretomanid and linezolid for treatment of extensively drug resistant, intolerant or non-responsive multidrug resistant pulmonary tuberculosis
por: Conradie, Francesca, et al.
Publicado: (2020)

Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
por: Oehadian, Amaylia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ga391d3o0iakid1e8488e05vhe